Optimizing Treatment on Idiopathic Inflammatory Myopathies

Optimizing Treatment on Idiopathic Inflammatory Myopathies

As a T2T, our patients with idiopathic inflammatory myopathies will receive pulse therapies with methyprednisolone and/or human intravenous immunoglobulin, or only methyprednisolone at disease onset.

This scheme is an internal routine protocol of our Service.

To compare two groups of patients as described in Brief Summary.

Inclusion Criteria:

• Idiopathic inflammatory myopathies

Exclusion Criteria:

• Inclusion body myositis, muscular dystrophies, neoplasia-associated myopathies, overlapped myopathies, others myopathies